Revisit standards for approving long term drugs

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f1927 (Published 26 March 2013)
Cite this as: BMJ 2013;346:f1927

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

OpenUrlCrossRefMedline

The European Medicines Agency (EMA) approved 200 brand new drugs between 2000 and 2010. The 161 standard medicines—not orphans—included 84 destined for long term use, by patients with asthma, for example. A review of the regulator’s public …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL